The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 21, 2023
Filed:
Nov. 17, 2020
Applicant:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Inventors:
Babak Mehrara, Chappaqua, NY (US);
Jason Gardenier, Altona, NY (US);
Ira Savetsky, Cedarhurst, NY (US);
Omer Aras, New York, NY (US);
Assignee:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4412 (2006.01); A61P 7/10 (2006.01); A61K 38/13 (2006.01); A61K 31/436 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 9/06 (2006.01); A61K 45/06 (2006.01); A61K 31/4418 (2006.01); A61K 31/277 (2006.01); A61K 31/401 (2006.01); A61K 31/42 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4412 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/277 (2013.01); A61K 31/401 (2013.01); A61K 31/42 (2013.01); A61K 31/436 (2013.01); A61K 31/4418 (2013.01); A61K 38/13 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61P 7/10 (2018.01);
Abstract
Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti-TGF-β1 agent, or an anti-angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.